Paperonium

← Back to the plain-language case

Abstract reports P < 0.0001 for 3/170 vs 3/172 serious adverse events; the table gives P > 0.999

Nat Med (2025) Β· doi:10.1038/s41591-025-03674-y Β· PMC12092238

Summary

The abstract of this randomized trial (SUPPRESS-AF) says that procedure-related serious adverse events did not differ between PVI plus low-voltage-area ablation and PVI alone, and gives "1.7% versus 1.8%, P < 0.0001". The paper's own Extended Data Table 4 gives the counts behind those percentages, 3 of 170 and 3 of 172, and prints P > 0.999 for the same comparison with the test the Methods name (two-sided Fisher's exact test). Recomputed from those counts, Fisher's exact test gives P = 1.000. With six events in total, no split between the arms could give a two-sided Fisher P below 0.014. The words "no difference" are correct and the table is correct. The P value in the abstract is not, and a reader of the abstract alone sees a highly significant safety difference that the data do not show.

What the paper reports

Abstract:

There was no difference in the procedure-related serious adverse events between the two groups (1.7% versus 1.8%, P < 0.0001).

Extended Data Table 4, "Safety endpoints". This table is an image in the archived article; the text below was read from the publisher's image file (41591_2025_3674_Tab4_ESM.jpg). Columns: PVI+LVA-ABL n=170 | PVI-alone n=172 | p:

Procedure-related serious adverse events, n (%) | 3 (1.7) | 3 (1.8) | >0.999

Extended Data Table 4, footnote:

p for comparison between groups using the two-sided Fisher's exact test.

Methods, "Statistical analysis":

Safety endpoints were analyzed using Fisher's exact test. All tests were conducted at a two-sided Ξ± level of 0.05.

Results, "Safety endpoints":

There was no difference in procedure-related serious adverse events between the two groups. Case presentations of procedure-related serious adverse events are shown in Extended Data Table 6.

Discussion, fourth paragraph:

Serious, procedure-related, adverse event rates were not increased with the addition of LVA ablation.

Results, "Patients and follow-up" (the safety population):

A total of 342 patients were randomly assigned to either the LVA-ABL group (170 patients) or the PVI-alone group (172 patients) and safety outcomes were assessed.

Extended Data Table 6 (an image, read from 41591_2025_3674_Tab6_ESM.jpg) describes six cases: in PVI-alone, one cardiac tamponade, one stroke and one major bleeding; in PVI+LVA-ABL, one esophageal fistula and two major bleedings.

What the paper's own numbers show

Method. I took the counts and denominators from Extended Data Table 4 and checked them against the case list in Extended Data Table 6. I ran a two-sided Fisher's exact test on the 2Γ—2 table [[3, 167], [3, 169]], the test that the Methods and the table footnote name. As robustness checks I also ran one-sided Fisher tests, chi-square tests with and without continuity correction, and Fisher's test with the efficacy-population denominator (171) in place of 172. Because Fisher's test conditions on the total number of events, I listed every possible split of the six events and its P value, to find the smallest P these margins allow. I also found how many events the LVA arm would need, against 3/172, for P < 0.0001. Finally I recomputed the other rows of Extended Data Table 4 with the same test to confirm that the method reproduces the paper's printed values. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's numbers
Serious AEs, PVI+LVA-ABL Abstract; Ext. Data Table 4 3 (1.7%) of 170 3/170 = 1.76%
Serious AEs, PVI-alone Abstract; Ext. Data Table 4 3 (1.8%) of 172 3/172 = 1.74% (3/171 = 1.75%)
Case count Ext. Data Table 6 6 cases 3 PVI+LVA-ABL, 3 PVI-alone
P, serious AEs Abstract P < 0.0001 Fisher two-sided P = 1.000
P, serious AEs Ext. Data Table 4 >0.999 Fisher two-sided P = 1.000 (odds ratio 1.012)
P with denominator 171 robustness – 1.000
One-sided Fisher P robustness – 0.652 (greater) / 0.663 (less)
Chi-square P robustness – 1.000 (Yates); 0.988 (uncorrected)
Risk difference robustness – 0.02 percentage points (95% CI βˆ’2.76 to 2.80)
Lowest two-sided Fisher P over all splits of 6 events robustness – 0.014 (all six in PVI-alone); 0.030 (all six in PVI+LVA-ABL)
LVA-arm events needed for P < 0.0001 vs 3/172 robustness – 21/170 (12.4%), P = 8.7Γ—10⁻⁡
Bleeding events, 6 vs 2 Ext. Data Table 4 P = 0.173 P = 0.1727
Death from any cause, 2 vs 2 Ext. Data Table 4 >0.999 P = 1.000
Periprocedural AEs, 11 vs 4 Ext. Data Table 4; Discussion P = 0.069; OR 2.91 (0.91–9.31) P = 0.0692; OR 2.91 (Woolf CI 0.91–9.31)
Symptomatic stroke, 4 vs 2 Ext. Data Table 4 2 (1.7%), P = 0.723 2/172 = 1.16%, P = 0.447; with 3/172: 1.74%, P = 0.723

The same procedure reproduces the printed P values for bleeding, death and periprocedural events, and the table's own >0.999 for serious adverse events. Only the abstract's value disagrees.

Two smaller points, which do not bear on the main finding. First, 3/170 = 1.76% and 3/172 = 1.74%, so ordinary rounding would give 1.8% and 1.7%; the printed 1.7% and 1.8% appear in swapped order, in both the abstract and the table. Second, in the symptomatic stroke row the PVI-alone entry "2 (1.7)" is internally inconsistent: 2/172 is 1.2%, and Fisher's test on 4 vs 2 gives P = 0.447, whereas 3/172 gives both the printed 1.7% and the printed P = 0.723. The count may be 3 rather than 2; the paper does not say which entry is correct.

Figure

Abstract and Extended Data Table 4 give different P values for the same counts

Figure 1. The two places the paper reports the comparison of procedure-related serious adverse events. The left panel quotes the abstract and the right panel reproduces the relevant row of Extended Data Table 4: the same percentages, the same counts and a footnote naming the two-sided Fisher exact test. The printed P values (orange) are P < 0.0001 and P > 0.999. The blue box gives the two-sided Fisher exact P recomputed from the table's counts, 3/170 vs 3/172, which is 1.000 and agrees with the table.

All possible splits of six events and their Fisher P values

Figure 2. Given the arm sizes (170 and 172) and six events in total, these are the seven possible splits of the events. Bar heights are the probability of each split if the arms do not differ (hypergeometric distribution), and each bar is labelled with its two-sided Fisher exact P. The reported split, 3 vs 3, is the most likely split and has P = 1.000. The most extreme splits give P = 0.030 and 0.014, so no arrangement of six events in these arms could yield the P < 0.0001 printed in the abstract (orange text). All values are computed in recompute.py.txt.

Why it matters

The abstract is the part of the paper most readers see, and it is what indexing services and summaries reproduce. Read alone, "P < 0.0001" signals a highly significant difference in serious procedural harm between the two ablation strategies, the opposite of what the counts show and of what the same sentence says in words. A reader who notices the clash cannot tell from the abstract which part is wrong.

The effect on the paper's conclusions is small. The Results, Discussion and Extended Data Table 4 all report no difference, the table's P value is correct, and the primary efficacy result (61% vs 50% freedom from AF or AT, log-rank P = 0.127) does not depend on this value. The correct P (about 1.0) leaves the paper's safety reading unchanged: adding LVA ablation did not increase procedure-related serious adverse events in this trial. The trial is small for this endpoint, however (six events in total, risk-difference 95% CI about βˆ’2.8 to +2.8 percentage points), and the Discussion itself notes a tendency toward more periprocedural adverse events with LVA ablation (11 vs 4, P = 0.069). That point is separate and is not affected by this error.

Explanations considered

Status

As of 2026-10-23:

Suggested correction

  1. In the abstract, replace "(1.7% versus 1.8%, P < 0.0001)" with the value in Extended Data Table 4, for example "(3/170 (1.8%) versus 3/172 (1.7%), P > 0.999)".
  2. Check the order of the percentages for this row in the abstract and in Extended Data Table 4: 3/170 rounds to 1.8% and 3/172 to 1.7%.
  3. Check the symptomatic stroke row of Extended Data Table 4: the PVI-alone entry "2 (1.7)" with P = 0.723 is consistent with 3 events, not 2. Correct either the count or the percentage and P value.
  4. Optional: in the Discussion, the periprocedural adverse event percentages are labelled "95% CI" ("11 (95% CI = 6.5%) versus 4 (95% CI = 2.3%) patients"); they are proportions, not confidence intervals.